Evidence map›Paper›PMID 30618737›Full record

ArticleFrontiers in pharmacology2018

Intensive Glucose Control Reduces the Risk Effect of

Fazhong He, Yan Shu, Xingyu Wang, Xin Liu, Guojing Liu, Zhangren Chen, Zhenmin Wang, Ling Li, Rong Liu, Honghao Zhou and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. AnCurrent diabetes reviews · 2024
    Article
  5. LncRNAInternational journal of molecular sciences · 2022
    Article
  6. Tribbles pseudokinase 3 (Annals of translational medicine · 2021
    Article
  7. Annals of translational medicine · 2020
    Article
  8. Polytropic Influence ofFrontiers in pharmacology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Fazhong HeDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Yan ShuDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD, United States.
Xingyu WangBeijing Hypertension League Institute, Beijing, China.
Xin LiuBeijing Hypertension League Institute, Beijing, China.
Guojing LiuDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Zhangren ChenDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Zhenmin WangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Ling LiDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Rong LiuDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Honghao ZhouDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Heng XuDepartment of Laboratory Medicine, Precision Medicine Center, and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China.
Wei ZhangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Gan ZhouDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Central South University · CNXiangya Hospital Central South University · CNShanghai Institute of Hypertension · CNPharmacoGenetics (China) · CNSichuan University · CNUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus is a complex disease. Our previous study revealed that

Indexed as

cardiovascular diseasegenetic variationindividualized drug therapyintensive glucose controltype 2 diabetes

Identifiers

PMID30618737
PMCPMC6297143
OpenAlexW2905374376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.